A comparison between the effects of icodextrin and glucose 2.27% on plasma volume in peritoneal dialysis patients

• Conditions: renal failure; renal insufficiency; 10038430

• Registration Number: NL-OMON30588
• Lead Sponsor: Academisch Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 12

Inclusion Criteria

clinical stable patients treated with peritoneal dialysis

Exclusion Criteria

chronic heart failure NYHA III or higher
known hypersensitivity to icodextrin
pacemaker
pregnancy
younger than 18 years
inability to give informed consent
within one month of peritonitis
patients unable to stop icodextrin on clinical grounds

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>In this study the effects of glucose 2.27% and icodextrin 7.5% will be compared<br /><br>for the long dwell on plasma volume, extracellular volume and blood pressure<br /><br>control.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>xx</p><br>